Stay updated with breaking news from Nasdaq Pcvx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CEO Grant Pickering sold 15,000 shares of Vaxcyte stock in a transaction on Tuesday, April 23rd. The shares were sold at an average price of $61.92, for a total value of $928,800.00. Following the completion of the sale, the chief executive officer now directly owns 477,847 shares of […]
Vaxcyte (NASDAQ:PCVX – Get Free Report) and Avalon GloboCare (NASDAQ:ALBT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Profitability This table compares Vaxcyte and Avalon GloboCare’s net […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) CFO Andrew Guggenhime sold 8,000 shares of the company’s stock in a transaction on Thursday, April 18th. The shares were sold at an average price of $61.27, for a total value of $490,160.00. Following the completion of the transaction, the chief financial officer now directly owns 95,679 shares […]
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Free Report) have received an average recommendation of “Buy” from the five ratings firms that are currently covering the stock, Marketbeat reports. Five research analysts have rated the stock with a buy recommendation. The average 1-year price objective among brokerages that have issued ratings on the stock in […]
Vaxcyte (NASDAQ:PCVX – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($1.82) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.89) by ($0.93), Briefing.com reports. During the same quarter in the prior year, the business posted ($0.73) earnings per share. Vaxcyte Price Performance Vaxcyte stock traded […]